Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma clinical trials

Explore recruiting relapsed refractory cd19 acute lymphoblastic leukemia and diffuse large b cell lymphoma or primary mediastinal b cell lymphoma clinical trials.

Also recruiting in Europe

Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II study of anti-CD19 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by relapsed/refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma (DLBCL) or Primary Mediastinal B Cell Lymphoma (PML)

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma trials by city

Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Toronto Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Vancouver Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Montreal Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Calgary Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Edmonton Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Ottawa Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Winnipeg Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Quebec City Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Hamilton Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Kitchener Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in London Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Halifax Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in New York Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Los Angeles Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Chicago Relapsed Refractory Cd19 Acute Lymphoblastic Leukemia And Diffuse Large B Cell Lymphoma Or Primary Mediastinal B Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease